Insider · CIK 0001510720
Theresa Wingrove
officer
Files at IMGN (ImmunoGen, Inc.). First filing Oct 18, 2023, latest Feb 6, 2024.
In brief
Theresa Wingrove files SEC Form 4 as officer at IMGN (ImmunoGen, Inc.). Since Oct 18, 2023, Theresa Wingrove has reported 0 open-market buys worth $0 and 7 open-market sells worth $20M, the latest filed on Feb 6, 2024.
A track record needs three past buys with six months of prices behind them; Theresa Wingrove has 0, so none is measured yet.
The newest scored trade: sold $352k of IMGN on Feb 5, 2024, filed Feb 6, 2024, scored 20 (weak), under a 10b5-1 plan.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 7
$0 bought, $20M sold
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 20Weak | ImmunoGen, Inc. | $352k 12,027 shares | -36% | - | |
| 25Weak | ImmunoGen, Inc. | $5.6M 187,667 shares | -98% | - | |
| 33Weak | ImmunoGen, Inc. | $3.5M 117,445 shares | -98% | - | |
| 40Moderate | ImmunoGen, Inc. | $4.9M 171,216 shares | -1783% | - | |
| 40Moderate | ImmunoGen, Inc. | $2.6M 166,725 shares | -98% | - | |
| 30Weak | ImmunoGen, Inc. | $325k 19,517 shares | -87% | - | |
| 45Moderate | IMGNsell ImmunoGen, Inc. | $2.8M 192,004 shares | -99% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Feb 5, 2024 | IMGN ImmunoGen, Inc. | 12,027 0.00% of outstanding | $352k | Feb 5, 2024 | $23M |
| Jan 16, 2024 | IMGN ImmunoGen, Inc. | 187,667 0.07% of outstanding | $5.6M | Jan 16, 2024 | $14M |
| Dec 15, 2023 | ImmunoGen, Inc. | 117,445 0.04% of outstanding | $3.5M | Dec 15, 2023 | $14M |
| Nov 30, 2023 | ImmunoGen, Inc. | 164,424 0.06% of outstanding | $4.8M | Nov 30, 2023 | $8.8M |
| Nov 29, 2023 | ImmunoGen, Inc. | 6,792 0.00% of outstanding | $113k | Nov 29, 2023 | $8.7M |
| Nov 15, 2023 | ImmunoGen, Inc. | 166,725 0.06% of outstanding | $2.6M | Nov 15, 2023 | $6.1M |
| Nov 7, 2023 | ImmunoGen, Inc. | 19,517 0.01% of outstanding | $325k | Nov 7, 2023 | $5.7M |
| Oct 16, 2023 | ImmunoGen, Inc. | 192,004 0.08% of outstanding | $2.8M | Sep 15, 2023 | $3.0M |
Transactions
Every row this insider has filed, 50 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 12, 2024 | IMGN ImmunoGen, Inc. | DDisposition to issuer Common Stock | -21,039 | - | - | 0 | Feb 12, 2024 |
| Feb 12, 2024 | IMGN ImmunoGen, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -35,871 | - | - | 0 | Feb 12, 2024 |
| Feb 12, 2024 | IMGN ImmunoGen, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -121,905 | - | - | 0 | Feb 12, 2024 |
| Feb 12, 2024 | IMGN ImmunoGen, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -115,273 | - | - | 0 | Feb 12, 2024 |
| Feb 12, 2024 | IMGN ImmunoGen, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -140,400 | - | - | 0 | Feb 12, 2024 |
| Feb 12, 2024 | IMGN ImmunoGen, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -87,500 | - | - | 0 | Feb 12, 2024 |
| Feb 12, 2024 | IMGN ImmunoGen, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -12,666 | - | - | 0 | Feb 12, 2024 |
| Feb 12, 2024 | IMGN ImmunoGen, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -16,666 | - | - | 0 | Feb 12, 2024 |
| Feb 12, 2024 | IMGN ImmunoGen, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -1,333 | - | - | 0 | Feb 12, 2024 |
| Feb 12, 2024 | IMGN ImmunoGen, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -48,000 | - | - | 0 | Feb 12, 2024 |
| Feb 12, 2024 | IMGN ImmunoGen, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -9,267 | - | - | 0 | Feb 12, 2024 |
| Feb 12, 2024 | IMGN ImmunoGen, Inc. | DDisposition to issuer Restricted Stock Unitderivative | -48,360 | - | - | 0 | Feb 12, 2024 |
| Feb 12, 2024 | IMGN ImmunoGen, Inc. | DDisposition to issuer Restricted Stock Unitderivative | -21,364 | - | - | 0 | Feb 12, 2024 |
| Feb 2, 2024 | IMGN ImmunoGen, Inc. | MOption exercise Common Stock10b5-1 | +29,640 | $0.00 | $0 | 33,066 | Feb 6, 2024 |
| Feb 5, 2024 | IMGN ImmunoGen, Inc. | SOpen-market sale Common Stock10b5-1 | -12,027 | $29.30 | $352k | 21,039 | Feb 6, 2024 |
| Feb 2, 2024 | IMGN ImmunoGen, Inc. | MOption exercise Restricted Stock Unitderivative10b5-1 | -21,840 | $0.00 | $0 | 32,760 | Feb 6, 2024 |
| Feb 2, 2024 | IMGN ImmunoGen, Inc. | MOption exercise Restricted Stock Unitderivative10b5-1 | -7,800 | $0.00 | $0 | 15,600 | Feb 6, 2024 |
| Feb 1, 2024 | IMGN ImmunoGen, Inc. | AGrant or award Restricted Stock Unitderivative | +21,364 | $0.00 | $0 | 21,364 | Feb 5, 2024 |
| Jan 16, 2024 | IMGN ImmunoGen, Inc. | MOption exercise Common Stock10b5-1 | +58,900 | $4.83 | $284k | 62,326 | Jan 18, 2024 |
| Jan 16, 2024 | IMGN ImmunoGen, Inc. | MOption exercise Common Stock10b5-1 | +2,667 | $5.75 | $15k | 64,993 | Jan 18, 2024 |
| Jan 16, 2024 | IMGN ImmunoGen, Inc. | MOption exercise Common Stock10b5-1 | +126,100 | $5.25 | $662k | 191,093 | Jan 18, 2024 |
| Jan 16, 2024 | IMGN ImmunoGen, Inc. | SOpen-market sale Common Stock10b5-1 | -187,667 | $29.64 | $5.6M | 3,426 | Jan 18, 2024 |
| Jan 16, 2024 | IMGN ImmunoGen, Inc. | MOption exercise Stock Option (right to buy)derivative10b5-1 | -58,900 | $0.00 | $0 | 0 | Jan 18, 2024 |
| Jan 16, 2024 | IMGN ImmunoGen, Inc. | MOption exercise Stock Option (right to buy)derivative10b5-1 | -2,667 | $0.00 | $0 | 1,333 | Jan 18, 2024 |
| Jan 16, 2024 | IMGN ImmunoGen, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -126,100 | $0.00 | $0 | 0 | Jan 18, 2024 |
| Dec 29, 2023 | IMGN ImmunoGen, Inc. | AGrant or award Common Stock | +615 | $16.01 | $9,846 | 3,426 | Jan 3, 2024 |
| Dec 15, 2023 | IMGN ImmunoGen, Inc. | MOption exercise Common Stock10b5-1 | +27,788 | $4.55 | $126k | 30,599 | Dec 19, 2023 |
| Dec 15, 2023 | IMGN ImmunoGen, Inc. | MOption exercise Common Stock10b5-1 | +89,657 | $5.32 | $477k | 120,256 | Dec 19, 2023 |
| Dec 15, 2023 | IMGN ImmunoGen, Inc. | SOpen-market sale Common Stock10b5-1 | -117,445 | $29.40 | $3.5M | 2,811 | Dec 19, 2023 |
| Dec 15, 2023 | IMGN ImmunoGen, Inc. | MOption exercise Stock Option (right to buy)derivative10b5-1 | -27,788 | $0.00 | $0 | 35,871 | Dec 19, 2023 |
| Dec 15, 2023 | IMGN ImmunoGen, Inc. | MOption exercise Stock Option (right to buy)derivative10b5-1 | -89,657 | $0.00 | $0 | 115,273 | Dec 19, 2023 |
| Nov 29, 2023 | IMGN ImmunoGen, Inc. | MOption exercise Common Stock10b5-1 | +6,792 | $10.65 | $72k | 9,603 | Dec 1, 2023 |
| Nov 29, 2023 | IMGN ImmunoGen, Inc. | SOpen-market sale Common Stock10b5-1 | -6,792 | $16.66 | $113k | 2,811 | Dec 1, 2023 |
| Nov 30, 2023 | IMGN ImmunoGen, Inc. | MOption exercise Common Stock10b5-1 | +133,691 | $10.65 | $1.4M | 136,502 | Dec 1, 2023 |
| Nov 30, 2023 | IMGN ImmunoGen, Inc. | MOption exercise Common Stock10b5-1 | +30,733 | $10.79 | $332k | 167,235 | Dec 1, 2023 |
| Nov 30, 2023 | IMGN ImmunoGen, Inc. | SOpen-market sale Common Stock10b5-1 | -164,424 | $28.95 | $4.8M | 2,811 | Dec 1, 2023 |
| Nov 29, 2023 | IMGN ImmunoGen, Inc. | MOption exercise Stock Option (right to buy)derivative10b5-1 | -6,792 | $0.00 | $0 | 133,691 | Dec 1, 2023 |
| Nov 30, 2023 | IMGN ImmunoGen, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -133,691 | $0.00 | $0 | 0 | Dec 1, 2023 |
| Nov 30, 2023 | IMGN ImmunoGen, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -30,733 | $0.00 | $0 | 9,267 | Dec 1, 2023 |
| Nov 15, 2023 | IMGN ImmunoGen, Inc. | MOption exercise Common Stock10b5-1 | +166,725 | $4.55 | $759k | 169,536 | Nov 17, 2023 |
| Nov 15, 2023 | IMGN ImmunoGen, Inc. | SOpen-market sale Common Stock10b5-1 | -166,725 | $15.85 | $2.6M | 2,811 | Nov 17, 2023 |
| Nov 15, 2023 | IMGN ImmunoGen, Inc. | MOption exercise Stock Option (right to buy)derivative10b5-1 | -166,725 | $0.00 | $0 | 41,681 | Nov 17, 2023 |
| Nov 7, 2023 | IMGN ImmunoGen, Inc. | MOption exercise Common Stock10b5-1 | +19,517 | $10.65 | $208k | 22,328 | Nov 8, 2023 |
| Nov 7, 2023 | IMGN ImmunoGen, Inc. | SOpen-market sale Common Stock10b5-1 | -19,517 | $16.66 | $325k | 2,811 | Nov 8, 2023 |
| Nov 7, 2023 | IMGN ImmunoGen, Inc. | MOption exercise Stock Option (right to buy)derivative10b5-1 | -19,517 | $0.00 | $0 | 140,483 | Nov 8, 2023 |
| Oct 16, 2023 | IMGN ImmunoGen, Inc. | MOption exercise Common Stock | +158,641 | $4.55 | $722k | 161,452 | Oct 18, 2023 |
| Oct 16, 2023 | IMGN ImmunoGen, Inc. | MOption exercise Common Stock | +33,363 | $4.55 | $152k | 194,815 | Oct 18, 2023 |
| Oct 16, 2023 | IMGN ImmunoGen, Inc. | SOpen-market sale Common Stock | -192,004 | $14.40 | $2.8M | 2,811 | Oct 18, 2023 |
| Oct 16, 2023 | IMGN ImmunoGen, Inc. | MOption exercise Stock Option (right to buy)derivative | -158,641 | $0.00 | $0 | 63,659 | Oct 18, 2023 |
| Oct 16, 2023 | IMGN ImmunoGen, Inc. | MOption exercise Stock Option (right to buy)derivative | -33,363 | $0.00 | $0 | 208,406 | Oct 18, 2023 |
Questions about Theresa Wingrove
Answered from the filings on this page, as of the latest one.
Is Theresa Wingrove buying or selling?
Not in the last 12 months. Theresa Wingrove's latest open-market trade on SEC Form 4 was sold $352k of IMGN on Feb 5, 2024.
How did Theresa Wingrove's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Theresa Wingrove has 0.
Where does Theresa Wingrove file Form 4?
Theresa Wingrove has filed Form 4 at IMGN (ImmunoGen, Inc.) as SVP OF REGULATORY AFFAIRS. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.